Publications

Click to view citations

Books

  1. D.J. Burgess. Injectable Dispersed Systems, Formulation, Processing and Performance. Ed. D.J. Burgess, Drugs and The Pharmaceutical Sciences Series, Marcel Dekker, New York, (2005).
  2. J. Wright and D.J. Burgess: Controlled Release Science and Technology: Long Acting Injections and Implants, CRS Press, Springer, New York, 2012 http://dx.doi.org/10.1007/978-1-4614-0554-2

Recent Articles

  1. Kulkarni, R., Lalla, R.V., Hassan, M.F. et al. Formulation development and in vitro evaluation of extemporaneous mucoadhesive in situ forming orals gels for localized therapy. Drug Deliv. and Transl. Res. (2026). https://doi.org/10.1007/s13346-026-02223-5
  2. Kulkarni, D. Morales-Acosta, R.V. Lalla, D.J. Burgess. Impact of ions on the performance of mucoadhesive in situ forming oral gels. Journal of Drug Delivery Science and Technology 126, 108821, (2026)
  3. Malavia, N., Badole S., Sabatella, M., Bao, Q., & Burgess, D. J. (2026). Impact of polymer source variations on the development of LAI suspensions. International Journal of Pharmaceutical Excipients (accepted in pre-proof).
  4. Malavia, N., Bao, Q., Silva, D. A., Alam, K., Wang, Y., Lukacova, V., & Burgess, D. J. (2026). Mechanistic understanding of LAI suspension intramuscular depot formation: A physicochemical perspective. Journal of Controlled Release, 115177.
  5. Flanagan, D.J. Burgess, M. Duvnjak, N. Fotaki, K. Harris, K.M.H. Jain, D. Kou, A. McCartan, H. Mead, J. Milsmann, R. Mrsny, V. Paraskevopoulou, S. Thati, M. Venczel, D. Curran. “In Vitro Release Testing for Long Acting Injectables – a Workshop Summary Report”. The AAPS Journal 2026. 28:144.  https://doi.org/10.1208/s12248-026-01278-z
  6. Roy, X. Wang, Z. Hao, R. Wang, Y. Wang, B. Qin, Q. Li, Q. Zhang, D.J. Burgess “API particle size governs in situ forming implant formation, microstructure evolution and performance” Int. J. Pharmaceutics. 2026. 126951
  7. Bhorkade, B. Wan, P.K. Pandey, S. Dhurva, D.J. Burgess. “Residual Content Impacts Critical Quality Attributes and Performance of Risperidone Microspheres” Pharmaceutical Research. 2026 
  8. Kulkarni, R. Gokhale R. Lodayac, P. K. Pandey, A. Chathura, D.J. Burgess .“Spray freeze drying as a novel strategy to enhance oral delivery of proteins/peptides”. Int. J. Pharm. 2026, 126829. https://doi.org/10.1016/j.ijpharm.2026.126829
  9. Fanse, K. Maurus, S. Bhorkade, D.J. Burgess. “Loteprednol etabonate nanostructured lipid carriers for enhanced ocular bioavailability.” Colloids and Surfaces B: Biointerfaces, 2026. http://dx.doi.org/10.2139/ssrn.5733331
  10. Ranjbar, K. Shih, A.O Beringhs, B. Qin, Y.Wang, D.Zhang, W. Smith, A. Seyednejad, L. Burroughs, D.J. Burgess, R. Bahal, X. Lu. “Impact of ionizable lipid source on quality and stability of siRNA-loaded lipid nanoparticles”. J. Controlled Release, 2026, 114825. https://doi.org/10.1016/j.jconrel.2026.114825
  11. Malavia, K. Maurus, M. Sabatella, Q, Bao, Y. Wang, A. Khondoker and D.J. Burgess. “Impact of Macrophages on the dissolution of LAI Suspension Prodrugs” Int. J. Pharmaceutics. 2026, 126762. https://doi.org/10.1016/j.ijpharm.2026.126762
  12. Malavia and D.J. Burgess. “Insights into development of long-acting injectable suspensions” J. Controlled Release, 2026, 114721. https://doi.org/10.1016/j.jconrel.2026.114721.
  13. Khare, Y. Yanamadala, K. Harris K, D.J. Burgess, K. Gokulan, “Zileuton Nanocrystals Alter Intestinal Phase-I/II Metabolic Enzymes & Epithelial Permeability in Sex-Dependent Manner”, Drug Metabolism and Disposition Vol 1, 100218, 2026, https://doi.org/10.1016/j.dmd.2025.100218
  14. Li, M.D. Acosta, D.J. Burgess. “Liquid crystalline structure affects drug release from Pluronicâ gels. Int. J. Pharm. 2026, 126453. https://doi.org/10.1016/j.ijpharm.2025.126453.
  15. Silva, D.A., Le Merdy, M., Mullin, J. et al. Mechanistic Modeling of Intramuscular Administration of a Long-acting Injectable Accounting for Tissue Response At the Depot Site. AAPS J 28, 4 (2026). https://doi.org/10.1208/s12248-025-01171-1
  16. E. Durán, O. Yañez, P. Romero-Hasler, E. Soto, M. I. Osorio, A. Neira-Carrillo, I. Moreno-Villoslada, D. Gaete-Sanhueza, G. Álvarez-Acevedo, J. M. Ruso, D. J. Burgess, C. Valenzuela, F. Oyarzun-Ampuero, Iron dextran nanoparticles interacting with micrometric crosslinked protein scaffolds: Theoretical, computational and experimental results to design formulations for iron deficiency, International Journal of Biological Macromolecules, Volume 332, Part 2, 2025, 148522, ISSN 0141-8130, https://doi.org/10.1016/j.ijbiomac.2025.148522
  17. R. Kulkarni, S. Fanse, R. V. Lalla, D. Morales, D. J. Burgess, Mucoadhesive in situ forming Gels: Bridging Formulation design and physiological Realities, International Journal of Pharmaceutics, Volume 681, 2025, 125834, ISSN 0378-5173, https://doi.org/10.1016/j.ijpharm.2025.125834
  18. S. Fanse, D.J. Burgess. In vitro- in vivo relationship and microstructural insights into long-acting levonorgestrel intrauterine systems. J. Controlled release. 2025, 383:113858. https://doi.org/10.1016/j.jconrel.2025.113858 
  19. L. Burroughs, D.J. Burgess. How could the affordable, reliable and continuous production of lipid nanoparticles revolutionize healthcare? Nanomedicine. 2025. https://doi.org/10.1080/17435889.2025.2500911 
  20. A. Abhang, D.J. Burgess. Recent advancements and future applications of intrauterine drug delivery systems. Expert Opinion on Drug Delivery. 2025. https://doi.org/10.1080/17425247.2025.2490266 
  21. X. Wang, R. Wang, M. Roy, Y. Wang, B. Qin, D.J. Burgess. Understanding drug release mechanisms of risperidone in situ forming implant depots in rabbits. J. Controlled Release. 2025, 383:113785. https://doi.org/10.1016/j.jconrel.2025.113785 
  22. A.G. Clark, J. Wong, R. Wang, Y. Wang, B. Qin, D.J. Burgess, S. Zhang. Aging-induced microstructural evolution in risperidone loaded PLGA microspheres. Int. J. Pharmaceutics. 2025, 675 125512. https://doi.org/10.1016/j.ijpharm.2025.125512 
  23. E. Duran, P. Romero-Hasler, M.G.V. Sarmiento, G. Alvarez-Acevedo, E. Soto-Bustamante, A. Neira-Carrillo, F. Oyarzun-Ampuero, D.J. Burgess, C. Valenzuela, C.V. Venegas. Iron dextran-loaded alginate-calcium multi-vesicular microparticles as an intramuscular supplement: a new approach for in situ prolonged iron release. Food Structure. 2025, 43 100411. https://doi.org/10.1016/j.foostr.2025.100411 
  24. X. Wang, R. Wang, M. Roy, O. Kwok, D.J. Burgess. Long-acting injectable in situ forming implants: Impact of polymer attributes and API. Int. J. Pharmaceutics. 2025, 670:125080. https://doi.org/10.1016/j.ijpharm.2024.125080 
  25. D.A. Silva, M.L. Merdy, K.D. Alam, Y. Wang, Q. Bao, N. Malavia, D.J. Burgess and V. Lukacova. Development of mechanistic in vitro–in vivo extrapolation to support bioequivalence assessment of long-acting injectables. Pharmaceutics 2024, 16, 552. https://doi.org/10.3390/pharmaceutics16040552 
  26. N. Malavia, Q. Bao, D.A. Silva, Y. Wang, K. Alam, V. Lukacova, D.J. Burgess. Impact of agglomeration on in vitro performance of long-acting injectable suspensions. Int. J. Pharmaceutics. 2024, 673:125390. https://doi.org/10.1016/j.ijpharm.2025.125390 
  27. N. Malavia, Q. Bao, D.J. Burgess, Novel dissolution methods for drug release testing of Long-Acting injectables. Int. J. Pharm. 2024, 664:0378-5173. https://doi.org/10.1016/j.ijpharm.2024.124634
  28. S. Kharea, R. Jog, A. Bright, D.J. Burgess, S.K. Chakder and K. Gokulan. Evaluation of mucosal immune profile associated with Zileuton nanocrystal-formulated BCS-II drug upon oral administration in Sprague Dawley rats. Nanotoxicology. 2023,17(10):583-603. https://doi.org/10.1080/17435390.2023.2289940
  29. Y. Huang, S. Liangpunsakul, S. Rudraiah, J. Ma, S.K. Keshipeddy, D. Wright, A. Costa, D.J. Burgess, Y. Zhang, N. Huda, L. Wang, Z. Yang. HMGB2 is a potential diagnostic marker and therapeutic target for liver fibrosis and cirrhosis. Hepatol Commun. 7(11):e0299,Nov. 2023. https://doi.org/10.1097/HC9.0000000000000299
  30. X. Wang, Q. Bao, R. Wang, O. Kwok, K. Maurus, Y. Wang, B. Qin, D.J. Burgess. In situ forming risperidone implants: Effect of PLGA attributes on product performance. J. Controlled Release., 2023, 361:777-791. https://doi.org/10.1016/j.jconrel.2023.08.029
  31. X. Wang, Q. Bao, R. Wang, T. Li, Y. Wang, B. Qin, Q. Li, D.J. Burgess. In vivo characterization of Perseris and compositionally equivalent formulations. Int. J. Pharm. 2023, 642:123170. https://doi.org/10.1016/j.ijpharm.2023.123170
  32. A.G. Clark, R. Wang, J. Lomeo, Y. Wang, A. Zhu, M. Shen, Q. Bao, D.J. Burgess, B. Qin, S. Zhang. Investigating structural attributes of drug encapsulated microspheres with quantitative X-ray imaging. J. Controlled Release. 2023, 358:626-635. https://doi.org/10.1016/j.jconrel.2023.05.019
  33. B. Wan, Q. Bao, D.J. Burgess. Long-acting PLGA microspheres: advances in excipient and product analysis toward improved product understanding. Advanced Drug Delivery Reviews. 2023, 198:114857. https://doi.org/10.1016/j.addr.2023.114857
  34. X. Wang, Q. Bao, R. Wang, B. Wan, Y. Wang, B. Qin, D.J. Burgess. Reverse engineering of Perseris and development of compositionally equivalent formulations. Int. J. Pharm. 2023, 639: 122948. https://doi.org/10.1016/j.ijpharm.2023.122948 hk
  35. R. Holm, R.W. Lee, J. Glassco, N. DiFranco, Q. Bao, D.J. Burgess, V. Lukacova, S. Alidori. Long-acting injectable aqueous suspensions – Summary from an AAPS workshop. AAPS J. 2023, 25(3):49. doi: 10.1208/s12248-023-00811-8
  36. Q. Bao, X. Wang, B. Wan, Y. Zou, Y. Wang, D.J. Burgess. Development of in vitro-in vivo correlations for long-acting injectable suspensions. Int. J. Pharm. 2023, 634:122642. https://doi.org/10.1016/j.ijpharm.2023.122642
  37. R.H. Gudlavalleti, X. Xi, A. Legassey, P.Y. Chan, J. Li, D.J. Burgess, C. Giardina, F. Papadimitrakopoulos and F. Jain. Highly Miniaturized, Low-Power CMOS ASIC Chip for Long-Term Continuous Glucose Monitoring. Journal of Diabetes Science and Technology. 2023, Feb 11:19322968231153419. https://doi.org/10.1177/19322968231153419
  38. R. Kulkarni, S. Fanse, D.J. Burgess. Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part I: biophysical considerations. Expert Opinion on Drug Delivery. 2023, 20(3):395-412. https://doi.org/10.1080/17425247.2023.2181331
  39. R. Kulkarni, S. Fanse, D.J. Burgess. Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part II: formulation considerations. Expert Opinion on Drug Delivery. 2023, 20(3):413-434. https://doi.org/10.1080/17425247.2023.2181332
  40. Q. Bao, S. Fanse, X. Lu, D.J. Burgess. Impact of drug loading on release from levonorgestrel intrauterine systems. Int. J. Pharm. 2022, 631:122532. https://doi.org/10.1016/j.ijpharm.2022.122532
  41. S. Fanse, Q. Bao, D.J. Burgess. Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities. 2022, Advanced Drug Delivery Reviews, 191:114581. https://doi.org/10.1016/j.addr.2022.114581
  42. X. Wang, Q. Bao, A.G. Clark, Y. Wang, S. Zhang, D.J. Burgess. Characterization and in vitro release of minocycline hydrochloride microspheres prepared via coacervation. Int. J. Pharm. 2022, 628:122292. https://doi.org/10.1016/j.ijpharm.2022.122292
  43. A.G. Clark, R. Wang, Y. Qin, Y. Wang, A. Zhu, J. Lomeo, Q. Bao, D.J. Burgess, J. Chen, B. Qin, Y. Zou, S. Zhang. Assessing microstructural critical quality attributes in PLGA microspheres by FIB-SEM analytics. J. Controlled Release. 2022, 349:580–591. https://doi.org/10.1016/j.jconrel.2022.06.066
  44. Wan, Q. Bao, R. Wang, D.J. Burgess. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLG microspheres. Int. J. Pharm. 2022, 625:122032. https://doi.org/10.1016/j.ijpharm.2022.122032
  45. Wang, Q. Bao, M.S. Suh, M. Kastellorizios, R. Wang, D.J. Burgess. Novel adapter method for in vitro release testing of in situ forming implants. Int. J. Pharm. 2022, 621:121777. https://doi.org/10.1016/j.ijpharm.2022.121777
  46. Bao, X. Wang, Y. Zou, Y. Wang, D.J. Burgess. In vitro release testing method development for long-acting injectable suspensions. Int. J. Pharm. 2022, 622:121840. https://doi.org/10.1016/j.ijpharm.2022.121840
  47. Wan, Q. Bao, D.J. Burgess. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature. Journal of Controlled Release. 2022, 347:347–355. https://doi.org/10.1016/j.jconrel.2022.05.014
  48. Yenduri, A.P. Costa, X. Xu, D.J. Burgess. Impact of critical process parameters and critical material attributes on the critical quality attributes of liposomal formulations prepared using continuous processing. Int. J. Pharm. 2022, 619:121700. https://doi.org/10.1016/j.ijpharm.2022.121700
  49. Duran, A. Costa, A. Gupta, X. Xu, H. Zhang, D.J. Burgess, B. Chaudhuri. Coarse-Grained Molecular Dynamics Simulations of Paclitaxel-Loaded Polymeric Micelles. Molecular pharmaceutics. 2022, 19(4):1117-1134. https://doi.org/10.1021/acs.molpharmaceut.1c00800
  50. Li, B. Wan, R. Jog, A. Costa, D.J. Burgess. Pectin microparticles for peptide delivery: Optimization of spray drying processing. Int. J. Pharm. 2022, 613:121384. https://doi.org/10.1016/j.ijpharm.2021.121384
  51. S. Fanse. Q. Bao. Y. Zou. Y. Wang. D.J. Burgess. Impact of polymer crosslinking on release mechanisms from long-acting levonorgestrel intrauterine systems. Int. J. Pharm. 2022, 612:121383. https://doi: 10.1016/j.ijpharm.2021.121383
  52. He, E. Renard, P. Lord, D. Cohen, B. Gu, X. Wang, G. Yenduri, D.J. Burgess. Strategies for extended lifetime of implantable intraperitoneal insulin catheters. J. Controlled Release. 2022, 341:487-497. https://doi.org/10.1016/j.jconrel.2021.11.038
  53. Wan, Q. Bao, Y. Zou, Y. Wang, D.J. Burgess. Effect of polymer source variation on the properties and performance of risperidone microspheres Int. J. Pharm. 2021, 610:121265. https://doi.org/10.1016/j.ijpharm.2021.121265
  54. Fanse, Q. Bao, Y. Zou, Y. Wang, D.J. Burgess. Effect of crosslinking on the physicochemical properties of polydimethylsiloxane-based levonorgestrel intrauterine systems. Int. J. Pharm. 2021, 609:121192. https://doi.org/10.1016/j.ijpharm.2021.121192
  55. Wang, D.J. Burgess. Drug release from in situ forming implants and advances in release testing. Advanced Drug Delivery Reviews, 2021, 178:113912. https://doi.org/10.1016/j.addr.2021.113912
  56. He, E. Renard, P. Lord, D. Cohen, E. Cem-Duranty, J. Place, B. Gu, X. Wang, G. Yenduri, D.J. Burgess. Root cause determination of intraperitoneal catheter obstructions: Insulin amyloid aggregates vs foreign body reaction. J. Controlled Release. 2021, 336:1-15. https://doi.org/10.1016/j.jconrel.2021.06.005
  57. B Wan, J.V. Andhariya, Q Bao, Y Wang, Y Zou, J. Burgess. Effect of polymer source on in vitro drug release from PLGA microspheres. Journal of Pharmaceutics, 2021, 607. https://doi.org/10.1016/j.ijpharm.2021.120907
  58. Gupta, A.P. Costa, X. Xu, and D.J. Burgess. Continuous processing of Paclitaxel polymeric micelles. Int. J. Pharm. 2021, 607:120946. https://doi.org/10.1016/j.ijpharm.2021.120946
  59. Sansare, T. Duran, H. Mohammadiarani, M. Goyal, G. Yenduri, A. Costa, X. Xu, T. O’Connor, D.J. Burgess, B. Chaudhuri. Artificial neural networks in tandem with molecular descriptors as predictive tools for continuous liposome manufacturing. Int. J. Pharm. 2021, 603:120713. https://doi.org/10.1016/j.ijpharm.2021.120713
  60. Ochi, B. Wan, Q. Bao and D.J. Burgess. Influence of PLGA molecular weight distribution on leuprolide release from microspheres. Int. J. Pharm. 2021, 599:120450. https://doi.org/10.1016/j.ijpharm.2021.120450
  61. Bao, Y. Zou, Y. Wang, S. Choi, D.J. Burgess. Impact of formulation parameters on in vitro release from long-acting injectable suspensions. The AAPS Journal, March 2021, 23:42. https://doi.org/10.1208/s12248-021-00566-0
  62. Li and D.J. Burgess. Biomarker monitoring and long-acting insulin treatment in a stress model to facilitate personalized diabetic control. Journal of Controlled Release. 2021, 332:21–28. https://doi.org/10.1016/j.jconrel.2021.02.013
  63. Li, R.V. Lalla, and D.J. Burgess. Enhanced drug loading of in situ forming gels for oral mucositis pain control. Int. J. Pharm. 2021, 595:12022. https://doi.org/10.1016/j.ijpharm.2021.120225
  64. S. Suh, M. Kastellorizios, N. Tipnis, Y. Zou, Y. Wang, S. Choi, and D.J. Burgess. Effect of implant formation on drug release kinetics of in situ forming implants. Int. J. Pharm. 2021, 592:120105. https://doi.org/10.1016/j.ijpharm.2020.120105
  65. Tipnis, M. Kastellorizios, A. Legassey, F. Papadimitrakopoulos, F. Jain, D.J. Burgess. Sterilization of drug-loaded composite coatings for implantable glucose biosensors. J Diabetes Science and Technology. 2021, 15(3)646-654. https://doi.org/10.1016/j.jconrel.2019.10.01410.1177/1932296819890620
  66. Lu, B. Ning, N. Fotaki, S.S. Sharp, D.J. Burgess and S. Haddouchi. American Association of Pharmaceutical Scientists (AAPS) and Chinese National Institutes for Food and Drug Control (NIFDC) joint workshop on dissolution, bioequivalence, product performance, and quality. Dissolution Technologies, May 2020. https://dx.doi.org/10.14227/DT270220P42
  67. Li, D.J. Burgess. Nanomedicine based drug delivery towards tumor biological and immunological microenvironment. ACTA PHARM SIN B. 2020, 10(11):2110-2124. https://doi.org/10.1016/j.apsb.2020.05.008
  68. Bao, M.D. Morales-Acosta, D.J. Burgess. Physicochemical attributes of white petrolatum from various sources used for ophthalmic ointment formulations. Int. J. Pharm. 2020, 583:119381. https://doi.org/10.1016/j.ijpharm.2020.119381
  69. Gupta, A.P. Costa, X. Xu, S.L. Lee, C.N Cruz, Q. Bao, D.J. Burgess. Formulation and characterization of curcumin loaded polymeric micelles produced via continuous processing. Int. J. Pharm. 2020, 583:119340. https://doi.org/10.1016/j.ijpharm.2020.119340
  70. Kohno, J.V. Andhariya, B. Wan, Q. Bao, S. Rothstein, M. Hezel, Y. Wang, D.J. Burgess. The effect of PLGA molecular weight differences on risperidone release from microspheres. Int. J. Pharm. 2020, 582:119339. https://doi.org/10.1016/j.ijpharm.2020.119339
  71. Li, Q. Bao, J. Shen, R.V. Lalla, D.J. Burgess. Mucoadhesive in situ forming gel for oral mucositis pain control. Int. J. Pharm. 2020, 580:119238. https://doi.org/10.1016/j.ijpharm.2020.119238
  72. P. Tipnis, J. Shen, D. Jackson, D. Leblanc, D.J. Burgess. Flow-through cell-based in vitro release method for triamcinolone acetonide poly (lactic-co-glycolic) acid microspheres. Int. J. Pharm. 2020, 579:119130. https://doi.org/10.1016/j.ijpharm.2020.119130
  73. Bao. Y. Zou. Y. Wang S. Choi. D.J. Burgess. Impact of product design parameters on in vitro release from intrauterine systems. Int. J. Pharm. 2020, 578:119135. https://doi.org/10.1016/j.ijpharm.2020.119135
  74. Bao. Y. Zou, Y. Wang, D. Kozak, S. Choi, D.J. Burgess. Drug release testing of long-acting intrauterine systems. J. Controlled Release. 2019, 316:349–358. https://doi.org/10.1016/j.jconrel.2019.11.015
  75. V. Andhariya, R. Jog, J. Shen, S. Choi, Y. Wang, Y. Zou, D.J. Burgess. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release. J. Control Release. 2019, 314:25-37. https://doi.org/10.1016/j.jconrel.2019.10.014
  76. V. Andhariya, R. Jog, J. Shen, S. Choi, Y. Wang, Y. Zou, D.J. Burgess. Development of level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. J. Controlled Release, 2019, 308: 1-13. https://doi.org/10.1016/j.jconrel.2019.07.013
  77. Wang, N. Meng, S. Wang, Y. Zhang, L. Lu, R. Wang, H. Ruan, K. Jiang, H. Wang, D. Ran, C. Zhan, K. Yu, D.J. Burgess, W. Lu. Non-immunogenic, low-toxicity and effective glioma targeting MTI-31liposomes. J. Controlled Release. 2019, 316:381–392. https://doi.org/10.1016/j.jconrel.2018.12.003
  78. R. Pace, R. Jog, D.J. Burgess, M.K. Hadden. Formulation and evaluation of itraconazole liposomes for Hedgehog pathway inhibition. Journal of Liposome Research. 2019, Oct 2:1-7. https://doi.org/10.1080/08982104.2019.1668011
  79. V.Andhariya, J. Shen, Y. Wang, S. Choi, D.J. Burgess. Effect of minor manufacturing changes on stability of compositionally equivalent PLGA microspheres. Int. J. Pharm. 2019, 566:532-540. https://doi.org/10.1016/j.ijpharm.2019.06.014
  80. Jog, D.J. Burgess. Comprehensive quality by design approach for stable nanocrystalline drug products. Int. J. Pharm. 2019, 564:426-460. https://doi.org/10.1016/j.ijpharm.2019.04.050
  81. Cui, C.M. O’Connell, A. Costa, Y. Pan, J.A. Smyth, Paulo, H. Verardi, D.J. Burgess, Herbert J. Van Kruiningen, A.E. Garmendia. A PRRSV GP5-Mosaic vaccine: Protection of pigs from challenge and ex vivo detection of IFNγ responses against several genotype 2 strains. PLos One. 2019, 14(1):e0208801. https://doi.org/10.1371/journal.pone.0208801
  82. Wang, H. Wang, K. Jiang, Y. Zhang, C. Zhan, M. Ying, M. Zhang, L. Lu, R. Wang, S. Wang, D.J. Burgess, H. Wang, W. Lu. Liposomes with cyclic RGD peptide motif triggers acute immune response in mice. J. Controlled Release. 2019, 293:201–214. https://doi.org/10.1016/j.jconrel.2018.12.003
  83. Bao, D.J. Burgess. Perspectives on physicochemical and in vitro profiling of ophthalmic ointments. Pharmaceutical Research. 2018, 35:234. https://doi.org/10.1007/s11095-018-2513-3
  84. Jog, D.J. Burgess. Nanoamorphous drug products — design and development. Int. J. Pharm. 2018, 553:238-260. https://doi.org/10.1016/j.ijpharm.2018.10.046
  85. Gu, F. Papadimitrakopoulos, D.J. Burgess. PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months. J. Controlled Release. 2018, 289:35-43. https://doi.org/10.1016/j.jconrel.2018.09.021
  86. Bao, Bing Gu, Claire F. Price, Yuan Zou, Yan Wang, Darby Kozak, Stephanie Choi, D.J. Burgess. Manufacturing and characterization of long-acting levonorgestrel intrauterine systems. Int. J. Pharm. 2018, 550:447–454. https://doi.org/10.1016/j.ijpharm.2018.09.004
  87. Bao, B. Newman, Y. Wang, S. Choi, D.J. Burgess. In vitro and ex vivo correlation of drug release from ophthalmic ointments. J. Control Release. 2018, 276:93–101. https://doi.org/10.1016/j.jconrel.2018.03.003
  88. Tipnis and D.J. Burgess. Sterilization of implantable polymer-based medical devices: A review, Int. J. Pharm. 2018. 544:455-460. https://doi.org/10.1016/j.ijpharm.2017.12.003